Seneste opdatering :
06/01/2025
Bibliografi   Bibliografi 4835  
Type : Journal
Internet-link : https://doi.org/10.1186/s40635-020-00311-5

forskerhold : Nottingham - School of Medicine, University of Nottingham, UK
Forfattere : Hammond S, Wignell A, Cooling P, Barrett D.A, Davies P.
Titel : Plasma-Lyte 148 and Plasma-Lyte 148 + 5% glucose compatibility with commonly used critical care drugs.
Nummer : Intensive Care Medecine Experimental 8:25. 2020

cotationvaleur : 
fysisk stabilitet : 
kemisk stabilitet : 
andre metoder : 
Kommentarer : 

Lister
InjektionDobutamine hydrochloride Kardoitonisk
Kompatibel 2 mg/ml + Plasmalyte 148 (Baxter)
Kompatibel 2 mg/ml +  Plasmalyte 148 dextrose 5% (Baxter)
InjektionDopamine hydrochloride Kardoitonisk
Kompatibel 4 mg/ml + Plasmalyte 148 (Baxter)
Kompatibel 4 mg/ml +  Plasmalyte 148 dextrose 5% (Baxter)
InjektionEpinephrine hydrochloride Sympatomimetisk
Kompatibel 30 µg/ml + Plasmalyte 148 (Baxter)
Kompatibel 30 µg/ml +  Plasmalyte 148 dextrose 5% (Baxter)
InjektionMidazolam hydrochloride Anxiolytisk
Uforenelig 3 mg/ml + Plasmalyte 148 (Baxter)
Uforenelig 3 mg/ml +  Plasmalyte 148 dextrose 5% (Baxter)
InjektionMilrinone lactate Kardoitonisk
Kompatibel 0,2 mg/ml + Plasmalyte 148 (Baxter)
Kompatibel 0,2 mg/ml +  Plasmalyte 148 dextrose 5% (Baxter)

  Mentions Légales